PREVENTION OF SUDDEN CARDIAC DEATH AFTER MYOCARDIAL INFARCTION BY DEFIBRILLATOR IMPLANTATION

Prevention of sudden cardiac death: from analysis of existing data to a large-scale clinical trial

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847999.

Latest news

THE START OF THE PROFID EHRA CLINICAL TRIAL
With the initiation of the first clinical study sites in Bad Segeberg and Rothenburg, Germany, and the enrolment of the first patients, the PROFID EHRA trial has finally started.  From now on the 30-month recruitment period is underway. The PROFID EHRA trial (NCT05665608) is set to answer the question if routine implantation of an implantable …

Project Information

Grant agreement ID: 847999

DOI: 10.3030/847999

Start date: 1st January 2020
End date: 31st December 2024

Funded under: SOCIETAL CHALLENGES – Health, demographic change and well-being

Overall budget: € 23,307,508.08

Coordinated by: Helios Health Institute GmbH


Newsletter

SIgn up for the profid newsletter